Medicinal Products

Sitagliptin/metforminklorid Accord

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Sitagliptin/metforminklorid Accord
Active Substance sitagliptinklorid hidrat
metforminklorid
Prescription Medicinal product subject to medical prescription
Type of prescription Medicinal product on medical prescription for renewable delivery
Distribution Supply through pharmacies (community)
ATC Code A10BD07
Marketing status Never marketed
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download

Packaging

Back